Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Sell
95,177
-5,223
-5% -$139K 0.15% 102
2025
Q4
$2.5M Sell
100,400
-1,065
-1% -$26.9K 0.13% 102
2025
Q3
$2.59M Buy
101,465
+382
+0.4% +$9.43K 0.14% 100
2025
Q2
$2.45M Sell
101,083
-1,432
-1% -$33.4K 0.15% 99
2025
Q1
$2.6M Sell
102,515
-6,455
-6% -$169K 0.17% 97
2024
Q4
$2.89M Buy
108,970
+709
+0.7% +$19.2K 0.18% 93
2024
Q3
$3.13M Buy
108,261
+833
+0.8% +$24.3K 0.19% 92
2024
Q2
$3.01M Buy
107,428
+1,820
+2% +$50.1K 0.19% 94
2024
Q1
$2.93M Buy
105,608
+19,448
+23% +$540K 0.19% 98
2023
Q4
$2.48M Buy
86,160
+37,829
+78% +$1.14M 0.17% 99
2023
Q3
$1.6M Buy
48,331
+2,049
+4% +$72.5K 0.12% 108
2023
Q2
$1.7M Sell
46,282
-425
-0.9% -$16.5K 0.12% 108
2023
Q1
$1.91M Sell
46,707
-9,276
-17% -$401K 0.14% 101
2022
Q4
$2.87M Sell
55,983
-695
-1% -$33.3K 0.22% 86
2022
Q3
$2.48M Sell
56,678
-15
-0% -$729 0.21% 87
2022
Q2
$2.97M Buy
56,693
+6,077
+12% +$310K 0.23% 90
2022
Q1
$2.62M Buy
50,616
+641
+1% +$33.3K 0.18% 99
2021
Q4
$2.95M Buy
49,975
+1,615
+3% +$80K 0.19% 92
2021
Q3
$2.08M Buy
48,360
+3,375
+8% +$150K 0.14% 98
2021
Q2
$1.76M Sell
44,985
-581
-1% -$22.6K 0.12% 106
2021
Q1
$1.65M Sell
45,566
-2,030
-4% -$72.1K 0.12% 100
2020
Q4
$1.75M Sell
47,596
-3,361
-7% -$123K 0.14% 96
2020
Q3
$1.77M Sell
50,957
-3,261
-6% -$114K 0.16% 89
2020
Q2
$1.68M Buy
54,218
+2,480
+5% +$84.3K 0.16% 94
2020
Q1
$1.6M Sell
51,738
-1,204
-2% -$41K 0.18% 92
2019
Q4
$1.97M Sell
52,942
-2,302
-4% -$82K 0.18% 94
2019
Q3
$1.88M Buy
55,244
+152
+0.3% +$5.53K 0.19% 97
2019
Q2
$2.26M Sell
55,092
-21,911
-28% -$870K 0.23% 83
2019
Q1
$3.1M Sell
77,003
-4,111
-5% -$165K 0.31% 67
2018
Q4
$3.36M Buy
81,114
+554
+0.7% +$23K 0.38% 55
2018
Q3
$3.37M Buy
80,560
+4,206
+6% +$162K 0.33% 55
2018
Q2
$2.63M Sell
76,354
-3,123
-4% -$107K 0.28% 68
2018
Q1
$2.67M Buy
79,477
+4,659
+6% +$160K 0.29% 64
2017
Q4
$2.57M Buy
74,818
+1,805
+2% +$61.5K 0.3% 64
2017
Q3
$2.47M Buy
73,013
+6,687
+10% +$215K 0.31% 68
2017
Q2
$2.11M Buy
66,326
+1,073
+2% +$33.8K 0.26% 70
2017
Q1
$2.12M Sell
65,253
-17,718
-21% -$559K 0.28% 68
2016
Q4
$2.56M Sell
82,971
-6,876
-8% -$210K 0.34% 57
2016
Q3
$2.89M Buy
89,847
+1,630
+2% +$54.5K 0.39% 46
2016
Q2
$2.95M Buy
88,217
+6,010
+7% +$192K 0.41% 45
2016
Q1
$2.31M Buy
82,207
+2,279
+3% +$65.1K 0.32% 61
2015
Q4
$2.45M Buy
79,928
+10,063
+14% +$317K 0.35% 56
2015
Q3
$2.08M Buy
69,865
+25,831
+59% +$828K 0.32% 61
2015
Q2
$1.4M Buy
44,034
+1,823
+4% +$59.4K 0.21% 81
2015
Q1
$1.39M Sell
42,211
-189
-0.4% -$6.01K 0.2% 81
2014
Q4
$1.25M Sell
42,400
-8,180
-16% -$235K 0.19% 82
2014
Q3
$1.42M Buy
50,580
+2,450
+5% +$68.8K 0.23% 74
2014
Q2
$1.35M Sell
48,130
-25,839
-35% -$737K 0.22% 74
2014
Q1
$2.25M Sell
73,969
-2,131
-3% -$63.5K 0.37% 59
2013
Q4
$2.21M Buy
76,100
+6,572
+9% +$191K 0.37% 61
2013
Q3
$1.9M Sell
69,528
-617
-0.9% -$16.8K 0.34% 61
2013
Q2
$1.86M Buy
+70,145
New +$1.94M 0.35% 63

Other funds holding PFE

Spinnaker Trust's PFE Position: Q1 2026 in Review

Spinnaker Trust reduced its Pfizer (PFE) stake by 5.2% in Q1 2026, selling an estimated $139K and leaving 95,177 shares worth $2.67M. The position accounts for 0.15% of the portfolio, ranked #102.

Spinnaker Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.37M in Q3 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Spinnaker Trust held 95,177 shares of Pfizer worth $2.67M as of Q1 2026.
  • Spinnaker Trust sold 5,223 Pfizer shares in Q1 2026, an estimated $139K.
  • Pfizer made up 0.15% of Spinnaker Trust's portfolio in Q1 2026, its #102 holding.
  • Spinnaker Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Spinnaker Trust's Pfizer position peaked at $3.37M in Q3 2018.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.